FFL
BMY icon

Financial Freedom LLC’s Bristol-Myers Squibb BMY Stock Holding History

Financial Freedom LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8K Buy
409
+2
+0.5% +$117 0.01% 215
2025
Q4 		$21.9K Buy
407
+2
+0.5% +$96 0.01% 222
2025
Q3 		$18.3K Buy
405
+5
+1% +$234 0.01% 239
2025
Q2 		$18.5K Buy
400
+3
+0.8% +$147 0.01% 231
2025
Q1 		$24.2K Buy
397
+3
+0.8% +$175 0.01% 213
2024
Q4 		$22.3K Buy
394
+3
+0.8% +$168 0.01% 213
2024
Q3 		$20.2K Hold
391
– – 0.01% 221
2024
Q2 		$16.2K Buy
391
+261
+201% +$11.7K 0.01% 238
2024
Q1 		$7.07K Buy
130
+1
+0.8% +$51 ﹤0.01% 293
2023
Q4 		$6.61K Buy
129
+1
+0.8% +$52 ﹤0.01% 296
2023
Q3 		$7.4K Buy
128
+2
+2% +$123 0.01% 295
2023
Q2 		$8.08K Buy
126
+1
+0.8% +$67 0.01% 292
2023
Q1 		$8.69K Buy
125
+1
+0.8% +$71 0.01% 283
2022
Q4 		$8.95K Buy
+124
New +$9.35K 0.01% 276

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Freedom LLC's BMY Position: Q1 2026 in Review

Financial Freedom LLC increased its Bristol-Myers Squibb (BMY) stake by 0.49% in Q1 2026, buying an estimated $117 and bringing the position to 409 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #215.

Financial Freedom LLC first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Financial Freedom LLC held 409 shares of Bristol-Myers Squibb worth $24.8K as of Q1 2026.
  • Financial Freedom LLC bought 2 Bristol-Myers Squibb shares in Q1 2026, an estimated $117.
  • Bristol-Myers Squibb made up 0.01% of Financial Freedom LLC's portfolio in Q1 2026, its #215 holding.
  • Financial Freedom LLC first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.